| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |